Likewise, in vivo experiments in mice carrying MDA-MB-231 xenograft tumors with knocked-out HDAC9 exhibited significantly reduced tumor volumes post-paclitaxel treatment, compared to tumor-bearing mice with control sgRNA (Figure S3I and S3J). Here, HDAC9 is linked to neoplasm.